from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1356c/-

LFCtreatmentdescriptionclass of inhibitor

-0.025

Amikacinug/mL Amikacintranslation

0.878

Cap5-10ug/mL Capreomycintranslation

-0.004

Rox10-50 ug/mL Roxithromycintranslation

0.450

SM2-5 ug/mL Streptomycintranslation

-1.622

Tet5-10 ug/mL Tetracyclinetranslation

0.949

Rif0.2-5ug/mL Rifampicintranscription

-0.158

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.027

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.255

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.656

CPZ10-50 ug/mL Chlorpromazinerespiration

0.611

Clofazimine10-13 ug/mL Clofaziminerespiration

0.302

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.675

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.086

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.123

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.841

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.653

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.735

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.732

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.913

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.597

Nigericin50 uM Nigericinrespiration

-0.224

TRC10-150 ug/mL Triclosanrespiration

0.826

TRZ10-25 ug/mL Thioridazinerespiration

1.978

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.513

menadione6-10 ug/mL Menadionerespiration

0.729

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.152

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.086

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.727

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.639

NRP_1Non-replicating persistence stage 1dosRassociated

0.765

Amp0.2mg/mL AmpicillincellWall

-0.529

Cephalexin20-100 ug/mL CephalexincellWall

0.709

Cerulenin0.32-5 ug/mL CerulenincellWall

0.290

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.438

EMB10-20 ug/mL EthambutolcellWall

0.108

Eta12-40 ug/mL EthionamidecellWall

0.044

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.551

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.087

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.067

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.419

BZA0.12 mg/mL BenzamidearomaticAmides

0.188

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.083

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.253

H2O24 mM hydrogen peroxideDNAdamaging

-0.213

Levo10 ug/mL LevofloxacinDNAdamaging

-0.290

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.183

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.342

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.564

UVUV-irradiationDNAdamaging

0.327

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.692

Antimycin12.5-50 ug/mL Antimycin A?

-0.990

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.240

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.110

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.089

PA8240.2-2 ug/mL PA-824?

0.068

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.155

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.345

Verapamil50 uM Verapamil?

-0.304

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.706

methoxatin10-20 ug/mL Methoxatin?